Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/29/25 17:36 | 12/26/25 | QNCX | Health | BioPrd | Biological Products, (No Diag | Benatti Luca | CA | D | S | -174 | 3.47 | 0 | -50 | -56 | 39 | D | |||||||||||||||
12/8/25 08:12 | 12/5/25 | QNCX | Health | BioPrd | Biological Products, (No Diag | Hannah Brendan | CA | O | CBO,COO, | M.d | 25 | 0.9079 | 0 | 28 | 8 | 362 | D | ||||||||||||||
9/3/24 17:38 | 8/29/24 | QNCX | Health | BioPrd | Biological Products, (No Diag | Thye Dirk | CA | DO | CEO,CHIE | P.m | 107 | 0.6950 | 0 | 155 | 22 | 844 | D | ||||||||||||||
8/22/24 17:51 | 8/20/24 | QNCX | Health | BioPrd | Biological Products, (No Diag | Ryan Charles S. | CA | O | P | P | 31 | 0.6500 | 0 | 48 | 65 | 122 | D | ||||||||||||||
8/21/24 18:38 | 8/19/24 | QNCX | Health | BioPrd | Biological Products, (No Diag | Hannah Brendan | CA | O | CHIEF BU | P.m | 24 | 0.6209 | 0 | 39 | 15 | 297 | D | ||||||||||||||
6/5/24 14:37 | 6/4/24 | QNCX | Health | BioPrd | Biological Products, (No Diag | Hannah Brendan | CA | O | CHIEF BU | M.d | 31 | 0.5500 | 0 | 56 | 28 | 258 | D | ||||||||||||||
1/17/24 16:48 | 1/16/24 | QNCX | Health | BioPrd | Biological Products, (No Diag | Thye Dirk | CA | DO | CEO | M.d | 191 | 0.7932 | 0 | 241 | 54 | 689 | D | ||||||||||||||
12/14/23 18:21 | 12/12/23 | QNCX | Health | BioPrd | Biological Products, (No Diag | Lamond David | CA | D | P.m | 69 | 1.02 | 0 | 68 | 1 | 6,686 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |